FDA approves first treatment for Ebola, a Regeneron antibody cocktail
Companies, agencies, institutions, etc
The Food and Drug Administration
Ervebo
FDA
COVID-19
Regeneron Pharmaceuticals
DRC
Inmazeb
Eli Lilly
Trump
Ars Orbital Transmission
CNMN Collection
WIRED Media Group
Condé Nast
People
Beth Mole
Inmazeb
Mbandaka
George Yancopoulos
Donald Trump
Ars
Groups
West African
Physical locations
the North Kivu
Places
No matching tags
Locations
Democratic Republic of Congo
Ituri
Équateur Province
the North Kivu Province
US
Events
The 11th outbreak
Summary
The Food and Drug Administration on Tuesday issued the first-ever approval for a therapy against Ebola virus disease.Though the Ebola vaccine, Ervebo, earned approval late last year and proved 97.5 percent effective in preliminary trials, the newly approved therapy may be useful in addressing an ongoing outbreak in Democratic Republic of Congo, which began in June. The FDA’s approval of Regeneron’s Ebola antibody cocktail may bolster optimism that the FDA will issue EUAs.“As we apply the same sophisticated technologies and manufacturing capabilities against COVID-19, we hope this will be one of many demonstrations of how the power of science can be successfully deployed against dangerous infectious diseases,” Yancopoulos said in the press release.You must login or create an account to comment.Join the Ars Orbital Transmission mailing list to get weekly updates delivered to your inbox.
As said here by Beth Mole